SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016584
Filing Date
2019-11-07
Accepted
2019-11-07 07:31:24
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 555726
2 ex10-2.htm EX-10.2 59631
3 ex31-1.htm EX-31.1 15947
4 ex31-2.htm EX-31.2 15816
5 ex32-1.htm EX-32.1 7428
6 ex32-2.htm EX-32.2 7304
  Complete submission text file 0001493152-19-016584.txt   4133998

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE xtnt-20190930.xml EX-101.INS 679278
8 XBRL SCHEMA FILE xtnt-20190930.xsd EX-101.SCH 55041
9 XBRL CALCULATION FILE xtnt-20190930_cal.xml EX-101.CAL 77087
10 XBRL DEFINITION FILE xtnt-20190930_def.xml EX-101.DEF 185449
11 XBRL LABEL FILE xtnt-20190930_lab.xml EX-101.LAB 388359
12 XBRL PRESENTATION FILE xtnt-20190930_pre.xml EX-101.PRE 302428
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 191198152
SIC: 2836 Biological Products, (No Diagnostic Substances)